Cargando…
Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials
Atrial fibrillation (AF), the most common cardiac arrhythmia, confers a 5-fold risk of stroke that increases to 17-fold when associated with mitral stenosis. At this time, the most effective long-term solution to protect patients from stroke and thromboembolism is oral anticoagulation, either with v...
Autores principales: | Proietti, Riccardo, Joza, Jacqueline, Arensi, Andrea, Levi, Michael, Russo, Vincenzo, Tzikas, Apostolos, Danna, Paolo, Sagone, Antonio, Viecca, Maurizio, Essebag, Vidal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319717/ https://www.ncbi.nlm.nih.gov/pubmed/25678828 http://dx.doi.org/10.2147/MDER.S70672 |
Ejemplares similares
-
Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
por: AlTurki, Ahmed, et al.
Publicado: (2019) -
Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure
por: Samuel, Michelle, et al.
Publicado: (2020) -
Left atrial appendage isolation in atrial fibrillation catheter ablation: A meta‐analysis
por: AlTurki, Ahmed, et al.
Publicado: (2018) -
Nonpharmacological Therapies for Atrial Fibrillation
por: Caldwell, Jane C., et al.
Publicado: (2011) -
Stroke, Dementia, and Atrial Fibrillation: From Pathophysiologic Association to Pharmacological Implications
por: Russo, Vincenzo, et al.
Publicado: (2020)